ID   COQ8A_HUMAN             Reviewed;         647 AA.
AC   Q8NI60; Q5T7A5; Q63HK0; Q8NCJ6; Q9HBQ1; Q9NQ67;
DT   27-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   12-OCT-2022, entry version 172.
DE   RecName: Full=Atypical kinase COQ8A, mitochondrial {ECO:0000305};
DE            EC=2.7.-.- {ECO:0000269|PubMed:25498144};
DE   AltName: Full=Chaperone activity of bc1 complex-like {ECO:0000303|PubMed:11888884};
DE            Short=Chaperone-ABC1-like {ECO:0000303|PubMed:11888884};
DE   AltName: Full=Coenzyme Q protein 8A {ECO:0000305};
DE   AltName: Full=aarF domain-containing protein kinase 3 {ECO:0000312|HGNC:HGNC:16812};
DE   Flags: Precursor;
GN   Name=COQ8A {ECO:0000303|PubMed:27499294, ECO:0000312|HGNC:HGNC:16812};
GN   Synonyms=ADCK3 {ECO:0000312|HGNC:HGNC:16812}, CABC1
GN   {ECO:0000303|PubMed:11888884}; ORFNames=PP265;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   INDUCTION.
RX   PubMed=11888884;
RA   Iiizumi M., Arakawa H., Mori T., Ando A., Nakamura Y.;
RT   "Isolation of a novel gene, CABC1, encoding a mitochondrial protein that is
RT   highly homologous to yeast activity of bc1 complex.";
RL   Cancer Res. 62:1246-1250(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Skeletal muscle;
RA   Ievolella C., Stanchi F., Bertocco E., Millino C., Faulkner G., Valle G.,
RA   Lanfranchi G.;
RT   "Full length sequencing of some human and murine muscular transcript
RT   (Telethon Italy project B41).";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., Qiu X.,
RA   Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., Shu H., Chen X.,
RA   Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S., Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Small intestine;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF N-TERMINUS, X-RAY CRYSTALLOGRAPHY (1.64 ANGSTROMS) OF
RP   256-647, FUNCTION, SUBCELLULAR LOCATION, PATHWAY, DOMAIN, ACTIVITY
RP   REGULATION, MUTAGENESIS OF LYS-276; GLN-279; ALA-339; LYS-358; GLU-405;
RP   GLU-411; ASP-488; ASN-493; ASP-507 AND ARG-611, AND CHARACTERIZATION OF
RP   VARIANTS COQ10D4 TRP-299; CYS-429; SER-549 AND LYS-551.
RX   PubMed=25498144; DOI=10.1016/j.molcel.2014.11.002;
RA   Stefely J.A., Reidenbach A.G., Ulbrich A., Oruganty K., Floyd B.J.,
RA   Jochem A., Saunders J.M., Johnson I.E., Minogue C.E., Wrobel R.L.,
RA   Barber G.E., Lee D., Li S., Kannan N., Coon J.J., Bingman C.A.,
RA   Pagliarini D.J.;
RT   "Mitochondrial ADCK3 employs an atypical protein kinase-like fold to enable
RT   coenzyme Q biosynthesis.";
RL   Mol. Cell 57:83-94(2015).
RN   [9]
RP   INVOLVEMENT IN COQ10D4.
RX   PubMed=20580948; DOI=10.1016/j.mito.2010.05.008;
RA   Gerards M., van den Bosch B., Calis C., Schoonderwoerd K., van Engelen K.,
RA   Tijssen M., de Coo R., van der Kooi A., Smeets H.;
RT   "Nonsense mutations in CABC1/ADCK3 cause progressive cerebellar ataxia and
RT   atrophy.";
RL   Mitochondrion 10:510-515(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   FUNCTION.
RX   PubMed=21296186; DOI=10.1016/j.bbalip.2011.01.009;
RA   Xie L.X., Hsieh E.J., Watanabe S., Allan C.M., Chen J.Y., Tran U.C.,
RA   Clarke C.F.;
RT   "Expression of the human atypical kinase ADCK3 rescues coenzyme Q
RT   biosynthesis and phosphorylation of Coq polypeptides in yeast coq8
RT   mutants.";
RL   Biochim. Biophys. Acta 1811:348-360(2011).
RN   [12]
RP   TISSUE SPECIFICITY.
RX   PubMed=24270420; DOI=10.1172/jci69000;
RA   Ashraf S., Gee H.Y., Woerner S., Xie L.X., Vega-Warner V., Lovric S.,
RA   Fang H., Song X., Cattran D.C., Avila-Casado C., Paterson A.D.,
RA   Nitschke P., Bole-Feysot C., Cochat P., Esteve-Rudd J., Haberberger B.,
RA   Allen S.J., Zhou W., Airik R., Otto E.A., Barua M., Al-Hamed M.H.,
RA   Kari J.A., Evans J., Bierzynska A., Saleem M.A., Bockenhauer D., Kleta R.,
RA   El Desoky S., Hacihamdioglu D.O., Gok F., Washburn J., Wiggins R.C.,
RA   Choi M., Lifton R.P., Levy S., Han Z., Salviati L., Prokisch H.,
RA   Williams D.S., Pollak M., Clarke C.F., Pei Y., Antignac C., Hildebrandt F.;
RT   "ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10
RT   biosynthesis disruption.";
RL   J. Clin. Invest. 123:5179-5189(2013).
RN   [13]
RP   SUBUNIT, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LEU-214; ALA-215;
RP   ASN-216; PHE-217; GLY-218; GLY-219; LEU-220; ALA-221; VAL-222; GLY-223;
RP   LEU-224; GLY-225; PHE-226; GLY-227; ALA-228; LEU-229 AND ALA-230.
RX   PubMed=25216398; DOI=10.1021/ja505017f;
RA   Khadria A.S., Mueller B.K., Stefely J.A., Tan C.H., Pagliarini D.J.,
RA   Senes A.;
RT   "A Gly-zipper motif mediates homodimerization of the transmembrane domain
RT   of the mitochondrial kinase ADCK3.";
RL   J. Am. Chem. Soc. 136:14068-14077(2014).
RN   [14]
RP   INVOLVEMENT IN COQ10D4.
RX   PubMed=24218524; DOI=10.1136/jnnp-2013-306483;
RA   Liu Y.T., Hersheson J., Plagnol V., Fawcett K., Duberley K.E., Preza E.,
RA   Hargreaves I.P., Chalasani A., Laura M., Wood N.W., Reilly M.M.,
RA   Houlden H.;
RT   "Autosomal-recessive cerebellar ataxia caused by a novel ADCK3 mutation
RT   that elongates the protein: clinical, genetic and biochemical
RT   characterisation.";
RL   J. Neurol. Neurosurg. Psych. 85:493-498(2014).
RN   [15]
RP   FUNCTION.
RX   PubMed=25540914; DOI=10.1016/j.pep.2014.12.008;
RA   Wheeler B., Jia Z.;
RT   "Preparation and characterization of human ADCK3, a putative atypical
RT   kinase.";
RL   Protein Expr. Purif. 108:13-17(2015).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   FUNCTION, INTERACTION WITH THE COQ ENZYME COMPLEX, DOMAIN, X-RAY
RP   CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 256-647 IN COMPLEX WITH ANP NUCLEOTIDE,
RP   ACTIVITY REGULATION, AND MUTAGENESIS OF LYS-276 AND ASP-507.
RX   PubMed=27499294; DOI=10.1016/j.molcel.2016.06.030;
RA   Stefely J.A., Licitra F., Laredj L., Reidenbach A.G., Kemmerer Z.A.,
RA   Grangeray A., Jaeg-Ehret T., Minogue C.E., Ulbrich A., Hutchins P.D.,
RA   Wilkerson E.M., Ruan Z., Aydin D., Hebert A.S., Guo X., Freiberger E.C.,
RA   Reutenauer L., Jochem A., Chergova M., Johnson I.E., Lohman D.C.,
RA   Rush M.J., Kwiecien N.W., Singh P.K., Schlagowski A.I., Floyd B.J.,
RA   Forsman U., Sindelar P.J., Westphall M.S., Pierrel F., Zoll J.,
RA   Dal Peraro M., Kannan N., Bingman C.A., Coon J.J., Isope P., Puccio H.,
RA   Pagliarini D.J.;
RT   "Cerebellar ataxia and coenzyme Q deficiency through loss of unorthodox
RT   kinase activity.";
RL   Mol. Cell 63:608-620(2016).
RN   [18]
RP   INTERACTION WITH THE COQ ENZYME COMPLEX.
RX   PubMed=27499296; DOI=10.1016/j.molcel.2016.06.033;
RA   Floyd B.J., Wilkerson E.M., Veling M.T., Minogue C.E., Xia C., Beebe E.T.,
RA   Wrobel R.L., Cho H., Kremer L.S., Alston C.L., Gromek K.A., Dolan B.K.,
RA   Ulbrich A., Stefely J.A., Bohl S.L., Werner K.M., Jochem A.,
RA   Westphall M.S., Rensvold J.W., Taylor R.W., Prokisch H., Kim J.J.,
RA   Coon J.J., Pagliarini D.J.;
RT   "Mitochondrial protein interaction mapping identifies regulators of
RT   respiratory chain function.";
RL   Mol. Cell 63:621-632(2016).
RN   [19]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-341.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [20]
RP   VARIANTS COQ10D4 TRP-213; VAL-272; ASP-272 AND LYS-551.
RX   PubMed=18319072; DOI=10.1016/j.ajhg.2007.12.022;
RA   Mollet J., Delahodde A., Serre V., Chretien D., Schlemmer D., Lombes A.,
RA   Boddaert N., Desguerre I., de Lonlay P., de Baulny H.O., Munnich A.,
RA   Roetig A.;
RT   "CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia
RT   and seizures.";
RL   Am. J. Hum. Genet. 82:623-630(2008).
RN   [21]
RP   VARIANTS COQ10D4 CYS-514; SER-549 AND THR-584 DEL.
RX   PubMed=18319074; DOI=10.1016/j.ajhg.2007.12.024;
RA   Lagier-Tourenne C., Tazir M., Lopez L.C., Quinzii C.M., Assoum M.,
RA   Drouot N., Busso C., Makri S., Ali-Pacha L., Benhassine T., Anheim M.,
RA   Lynch D.R., Thibault C., Plewniak F., Bianchetti L., Tranchant C., Poch O.,
RA   DiMauro S., Mandel J.-L., Barros M.H., Hirano M., Koenig M.;
RT   "ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia
RT   associated with coenzyme Q10 deficiency.";
RL   Am. J. Hum. Genet. 82:661-672(2008).
RN   [22]
RP   VARIANTS COQ10D4 TRP-213; CYS-271; ASP-272; VAL-272; TRP-299; THR-304;
RP   VAL-304; CYS-429; SER-549 AND LYS-551.
RX   PubMed=22036850; DOI=10.1136/jnnp-2011-301258;
RA   Horvath R., Czermin B., Gulati S., Demuth S., Houge G., Pyle A.,
RA   Dineiger C., Blakely E.L., Hassani A., Foley C., Brodhun M., Storm K.,
RA   Kirschner J., Gorman G.S., Lochmuller H., Holinski-Feder E., Taylor R.W.,
RA   Chinnery P.F.;
RT   "Adult-onset cerebellar ataxia due to mutations in CABC1/ADCK3.";
RL   J. Neurol. Neurosurg. Psych. 83:174-178(2012).
RN   [23]
RP   VARIANT COQ10D4 ARG-602.
RX   PubMed=24048965; DOI=10.1007/8904_2013_251;
RA   Blumkin L., Leshinsky-Silver E., Zerem A., Yosovich K., Lerman-Sagie T.,
RA   Lev D.;
RT   "Heterozygous mutations in the ADCK3 gene in siblings with cerebellar
RT   atrophy and extreme phenotypic variability.";
RL   JIMD Rep. 12:103-107(2014).
RN   [24]
RP   INVOLVEMENT IN COQ10D4.
RX   PubMed=26818466; DOI=10.1111/cge.12742;
RA   Barca E., Musumeci O., Montagnese F., Marino S., Granata F., Nunnari D.,
RA   Peverelli L., DiMauro S., Quinzii C.M., Toscano A.;
RT   "Cerebellar ataxia and severe muscle CoQ10 deficiency in a patient with a
RT   novel mutation in ADCK3.";
RL   Clin. Genet. 90:156-160(2016).
RN   [25]
RP   VARIANTS COQ10D4 TRP-299 AND VAL-578.
RX   PubMed=27106809; DOI=10.1111/ene.13003;
RA   Hikmat O., Tzoulis C., Knappskog P.M., Johansson S., Boman H.,
RA   Sztromwasser P., Lien E., Brodtkorb E., Ghezzi D., Bindoff L.A.;
RT   "ADCK3 mutations with epilepsy, stroke-like episodes and ataxia: a POLG
RT   mimic?";
RL   Eur. J. Neurol. 23:1188-1194(2016).
CC   -!- FUNCTION: Atypical kinase involved in the biosynthesis of coenzyme Q,
CC       also named ubiquinone, an essential lipid-soluble electron transporter
CC       for aerobic cellular respiration (PubMed:25498144, PubMed:21296186,
CC       PubMed:25540914, PubMed:27499294). Its substrate specificity is
CC       unclear: does not show any protein kinase activity (PubMed:25498144,
CC       PubMed:27499294). Probably acts as a small molecule kinase, possibly a
CC       lipid kinase that phosphorylates a prenyl lipid in the ubiquinone
CC       biosynthesis pathway, as suggested by its ability to bind coenzyme Q
CC       lipid intermediates (PubMed:25498144, PubMed:27499294). Shows an
CC       unusual selectivity for binding ADP over ATP (PubMed:25498144).
CC       {ECO:0000269|PubMed:25498144, ECO:0000269|PubMed:27499294,
CC       ECO:0000305|PubMed:21296186, ECO:0000305|PubMed:25540914}.
CC   -!- ACTIVITY REGULATION: Autoinhibited by the N-terminal domain, containing
CC       the KxGQ motif, that completely occludes the typical substrate binding
CC       pocket. Nucleotide-binding relieves inhibition (PubMed:27499294).
CC       {ECO:0000269|PubMed:25498144, ECO:0000269|PubMed:27499294}.
CC   -!- PATHWAY: Cofactor biosynthesis; ubiquinone biosynthesis.
CC       {ECO:0000269|PubMed:25498144}.
CC   -!- SUBUNIT: Homodimer; homodimerizes via its transmembrane region
CC       (PubMed:25216398). Interacts with the multi-subunit COQ enzyme complex,
CC       composed of at least COQ3, COQ4, COQ5, COQ6, COQ7 and COQ9
CC       (PubMed:27499294, PubMed:27499296). {ECO:0000269|PubMed:25216398,
CC       ECO:0000269|PubMed:27499294, ECO:0000269|PubMed:27499296}.
CC   -!- INTERACTION:
CC       Q8NI60; Q8WTS1: ABHD5; NbExp=3; IntAct=EBI-745535, EBI-2813554;
CC       Q8NI60; Q6RW13: AGTRAP; NbExp=4; IntAct=EBI-745535, EBI-741181;
CC       Q8NI60; Q6RW13-2: AGTRAP; NbExp=6; IntAct=EBI-745535, EBI-11522760;
CC       Q8NI60; Q5T2L2: AKR1C8; NbExp=3; IntAct=EBI-745535, EBI-22006248;
CC       Q8NI60; Q9NU02: ANKEF1; NbExp=3; IntAct=EBI-745535, EBI-8464238;
CC       Q8NI60; Q9H0Y0: ATG10; NbExp=3; IntAct=EBI-745535, EBI-1048913;
CC       Q8NI60; Q3SXR2: C3orf36; NbExp=3; IntAct=EBI-745535, EBI-18036948;
CC       Q8NI60; Q96HJ3-2: CCDC34; NbExp=3; IntAct=EBI-745535, EBI-17641690;
CC       Q8NI60; P09496-2: CLTA; NbExp=3; IntAct=EBI-745535, EBI-4401010;
CC       Q8NI60; Q8IZR5-2: CMTM4; NbExp=3; IntAct=EBI-745535, EBI-17278014;
CC       Q8NI60; Q96DZ9-2: CMTM5; NbExp=6; IntAct=EBI-745535, EBI-11522780;
CC       Q8NI60; Q9NX76: CMTM6; NbExp=3; IntAct=EBI-745535, EBI-1054315;
CC       Q8NI60; P02458-1: COL2A1; NbExp=3; IntAct=EBI-745535, EBI-12375799;
CC       Q8NI60; O75208: COQ9; NbExp=11; IntAct=EBI-745535, EBI-724524;
CC       Q8NI60; Q9BSY9: DESI2; NbExp=3; IntAct=EBI-745535, EBI-12878374;
CC       Q8NI60; Q9BPU6: DPYSL5; NbExp=3; IntAct=EBI-745535, EBI-724653;
CC       Q8NI60; Q86UW9: DTX2; NbExp=3; IntAct=EBI-745535, EBI-740376;
CC       Q8NI60; Q96KS9: FAM167A; NbExp=3; IntAct=EBI-745535, EBI-10290462;
CC       Q8NI60; Q6ZNL6: FGD5; NbExp=3; IntAct=EBI-745535, EBI-7962481;
CC       Q8NI60; Q8TAC2: JOSD2; NbExp=3; IntAct=EBI-745535, EBI-12205593;
CC       Q8NI60; P13473-2: LAMP2; NbExp=3; IntAct=EBI-745535, EBI-21591415;
CC       Q8NI60; Q96B96: LDAF1; NbExp=8; IntAct=EBI-745535, EBI-7055862;
CC       Q8NI60; Q9H2C1: LHX5; NbExp=3; IntAct=EBI-745535, EBI-25835523;
CC       Q8NI60; Q99732: LITAF; NbExp=3; IntAct=EBI-745535, EBI-725647;
CC       Q8NI60; P0DP58-2: LYNX1; NbExp=3; IntAct=EBI-745535, EBI-21916939;
CC       Q8NI60; Q96M61: MAGEB18; NbExp=3; IntAct=EBI-745535, EBI-741835;
CC       Q8NI60; Q969L2: MAL2; NbExp=5; IntAct=EBI-745535, EBI-944295;
CC       Q8NI60; P27338: MAOB; NbExp=3; IntAct=EBI-745535, EBI-3911344;
CC       Q8NI60; Q6IN84: MRM1; NbExp=3; IntAct=EBI-745535, EBI-5454865;
CC       Q8NI60; Q9H2K0: MTIF3; NbExp=3; IntAct=EBI-745535, EBI-3923617;
CC       Q8NI60; Q69YL0: NCBP2AS2; NbExp=3; IntAct=EBI-745535, EBI-10986258;
CC       Q8NI60; Q6N063-2: OGFOD2; NbExp=3; IntAct=EBI-745535, EBI-22006224;
CC       Q8NI60; Q8N138: ORMDL3; NbExp=3; IntAct=EBI-745535, EBI-721750;
CC       Q8NI60; Q96AL5: PBX3; NbExp=3; IntAct=EBI-745535, EBI-741171;
CC       Q8NI60; Q58EX7-2: PLEKHG4; NbExp=3; IntAct=EBI-745535, EBI-21503705;
CC       Q8NI60; Q9UI14: RABAC1; NbExp=12; IntAct=EBI-745535, EBI-712367;
CC       Q8NI60; Q96HR9: REEP6; NbExp=9; IntAct=EBI-745535, EBI-750345;
CC       Q8NI60; Q96HR9-2: REEP6; NbExp=3; IntAct=EBI-745535, EBI-14065960;
CC       Q8NI60; P47804-3: RGR; NbExp=3; IntAct=EBI-745535, EBI-25834767;
CC       Q8NI60; Q8N5U6: RNF10; NbExp=3; IntAct=EBI-745535, EBI-714023;
CC       Q8NI60; Q9NS64: RPRM; NbExp=3; IntAct=EBI-745535, EBI-1052363;
CC       Q8NI60; Q9NTN9-3: SEMA4G; NbExp=3; IntAct=EBI-745535, EBI-9089805;
CC       Q8NI60; Q9Y371: SH3GLB1; NbExp=11; IntAct=EBI-745535, EBI-2623095;
CC       Q8NI60; O60902-3: SHOX2; NbExp=3; IntAct=EBI-745535, EBI-9092164;
CC       Q8NI60; O60906: SMPD2; NbExp=3; IntAct=EBI-745535, EBI-12828299;
CC       Q8NI60; Q9C004: SPRY4; NbExp=3; IntAct=EBI-745535, EBI-354861;
CC       Q8NI60; O60499-2: STX10; NbExp=3; IntAct=EBI-745535, EBI-12094584;
CC       Q8NI60; Q9UBB9: TFIP11; NbExp=13; IntAct=EBI-745535, EBI-1105213;
CC       Q8NI60; Q7Z6W1: TMCO2; NbExp=3; IntAct=EBI-745535, EBI-12807858;
CC       Q8NI60; Q8WW34: TMEM239; NbExp=5; IntAct=EBI-745535, EBI-9675724;
CC       Q8NI60; Q8WW34-2: TMEM239; NbExp=3; IntAct=EBI-745535, EBI-11528917;
CC       Q8NI60; O43399: TPD52L2; NbExp=3; IntAct=EBI-745535, EBI-782604;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:11888884,
CC       ECO:0000269|PubMed:25498144}. Membrane {ECO:0000255}; Single-pass
CC       membrane protein {ECO:0000255, ECO:0000305|PubMed:25216398}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8NI60-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NI60-2; Sequence=VSP_022351;
CC       Name=3;
CC         IsoId=Q8NI60-3; Sequence=VSP_022353;
CC       Name=4;
CC         IsoId=Q8NI60-4; Sequence=VSP_022352;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest levels in adrenal
CC       gland, heart, pancreas, nasal mucosa, stomach, uterus and skeletal
CC       muscle. {ECO:0000269|PubMed:24270420}.
CC   -!- INDUCTION: By p53/TP53. {ECO:0000269|PubMed:11888884}.
CC   -!- DOMAIN: Adopts an atypical protein kinase-like fold: while it adopts a
CC       core fold similar to that of well-characterized protein kinase-like
CC       domains, a number of features are positioned to inhibit the kinase
CC       activity: (1) an atypical AAAS motif in an alanine-rich (A-rich) loop
CC       that replaces the canonical glycine-rich (G-rich) nucleotide-binding
CC       loop and limits ATP binding by establishing an unusual selectivity for
CC       ADP and (2) an N-terminal domain, containing the KxGQ motif, that
CC       completely occludes the typical substrate binding pocket
CC       (PubMed:25498144). Nucleotide-binding opens the substrate binding
CC       pocket and flips the active site from inside the hydrophobic core into
CC       a catalytically competent, solvent-exposed posture (PubMed:27499294).
CC       {ECO:0000269|PubMed:25498144, ECO:0000269|PubMed:27499294}.
CC   -!- DISEASE: Coenzyme Q10 deficiency, primary, 4 (COQ10D4) [MIM:612016]: An
CC       autosomal recessive disorder characterized by childhood-onset of
CC       cerebellar ataxia and exercise intolerance. Patient manifest gait
CC       ataxia and cerebellar atrophy with slow progression. Additional
CC       features include brisk tendon reflexes and Hoffmann sign, variable
CC       psychomotor retardation and variable seizures.
CC       {ECO:0000269|PubMed:18319072, ECO:0000269|PubMed:18319074,
CC       ECO:0000269|PubMed:20580948, ECO:0000269|PubMed:22036850,
CC       ECO:0000269|PubMed:24048965, ECO:0000269|PubMed:24218524,
CC       ECO:0000269|PubMed:25498144, ECO:0000269|PubMed:26818466,
CC       ECO:0000269|PubMed:27106809}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. ADCK protein
CC       kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB073905; BAB91363.1; -; mRNA.
DR   EMBL; AJ278126; CAC00482.1; -; mRNA.
DR   EMBL; AF218003; AAG17245.1; -; mRNA.
DR   EMBL; AK074693; BAC11143.1; -; mRNA.
DR   EMBL; BX648860; CAH56132.1; -; mRNA.
DR   EMBL; AL353689; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC005171; AAH05171.2; -; mRNA.
DR   CCDS; CCDS1557.1; -. [Q8NI60-1]
DR   RefSeq; NP_064632.2; NM_020247.4. [Q8NI60-1]
DR   RefSeq; XP_005273258.1; XM_005273201.1. [Q8NI60-1]
DR   RefSeq; XP_011542540.1; XM_011544238.1. [Q8NI60-1]
DR   RefSeq; XP_011542541.1; XM_011544239.2. [Q8NI60-1]
DR   RefSeq; XP_011542542.1; XM_011544240.2.
DR   RefSeq; XP_011542543.1; XM_011544241.2. [Q8NI60-1]
DR   RefSeq; XP_016857341.1; XM_017001852.1. [Q8NI60-1]
DR   PDB; 4PED; X-ray; 1.64 A; A=256-647.
DR   PDB; 5I35; X-ray; 2.30 A; A=256-647.
DR   PDBsum; 4PED; -.
DR   PDBsum; 5I35; -.
DR   AlphaFoldDB; Q8NI60; -.
DR   SMR; Q8NI60; -.
DR   BioGRID; 121312; 110.
DR   IntAct; Q8NI60; 211.
DR   MINT; Q8NI60; -.
DR   STRING; 9606.ENSP00000355741; -.
DR   BindingDB; Q8NI60; -.
DR   ChEMBL; CHEMBL5550; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q8NI60; -.
DR   iPTMnet; Q8NI60; -.
DR   PhosphoSitePlus; Q8NI60; -.
DR   BioMuta; COQ8A; -.
DR   DMDM; 27923741; -.
DR   EPD; Q8NI60; -.
DR   jPOST; Q8NI60; -.
DR   MassIVE; Q8NI60; -.
DR   MaxQB; Q8NI60; -.
DR   PaxDb; Q8NI60; -.
DR   PeptideAtlas; Q8NI60; -.
DR   PRIDE; Q8NI60; -.
DR   ProteomicsDB; 73833; -. [Q8NI60-1]
DR   ProteomicsDB; 73834; -. [Q8NI60-2]
DR   ProteomicsDB; 73835; -. [Q8NI60-3]
DR   ProteomicsDB; 73836; -. [Q8NI60-4]
DR   Antibodypedia; 20768; 332 antibodies from 29 providers.
DR   DNASU; 56997; -.
DR   Ensembl; ENST00000366777.4; ENSP00000355739.3; ENSG00000163050.18. [Q8NI60-1]
DR   Ensembl; ENST00000366778.5; ENSP00000355740.1; ENSG00000163050.18. [Q8NI60-3]
DR   GeneID; 56997; -.
DR   KEGG; hsa:56997; -.
DR   MANE-Select; ENST00000366777.4; ENSP00000355739.3; NM_020247.5; NP_064632.2.
DR   UCSC; uc001hqm.2; human. [Q8NI60-1]
DR   CTD; 56997; -.
DR   DisGeNET; 56997; -.
DR   GeneCards; COQ8A; -.
DR   GeneReviews; COQ8A; -.
DR   HGNC; HGNC:16812; COQ8A.
DR   HPA; ENSG00000163050; Group enriched (skeletal muscle, tongue).
DR   MalaCards; COQ8A; -.
DR   MIM; 606980; gene.
DR   MIM; 612016; phenotype.
DR   neXtProt; NX_Q8NI60; -.
DR   OpenTargets; ENSG00000163050; -.
DR   Orphanet; 139485; Autosomal recessive ataxia due to ubiquinone deficiency.
DR   PharmGKB; PA25999; -.
DR   VEuPathDB; HostDB:ENSG00000163050; -.
DR   VEuPathDB; HostDB:ENSG00000288674; -.
DR   eggNOG; KOG1234; Eukaryota.
DR   GeneTree; ENSGT00940000156810; -.
DR   HOGENOM; CLU_006533_9_1_1; -.
DR   InParanoid; Q8NI60; -.
DR   OMA; QVERVMN; -.
DR   PhylomeDB; Q8NI60; -.
DR   TreeFam; TF300630; -.
DR   PathwayCommons; Q8NI60; -.
DR   SignaLink; Q8NI60; -.
DR   UniPathway; UPA00232; -.
DR   BioGRID-ORCS; 56997; 8 hits in 1110 CRISPR screens.
DR   ChiTaRS; COQ8A; human.
DR   GeneWiki; CABC1; -.
DR   GenomeRNAi; 56997; -.
DR   Pharos; Q8NI60; Tbio.
DR   PRO; PR:Q8NI60; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q8NI60; protein.
DR   Bgee; ENSG00000163050; Expressed in gastrocnemius and 100 other tissues.
DR   Genevisible; Q8NI60; HS.
DR   GO; GO:0031314; C:extrinsic component of mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0043531; F:ADP binding; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; IDA:UniProtKB.
DR   GO; GO:0016310; P:phosphorylation; IDA:UniProtKB.
DR   GO; GO:0006744; P:ubiquinone biosynthetic process; IMP:UniProtKB.
DR   CDD; cd13970; ABC1_ADCK3; 1.
DR   InterPro; IPR004147; ABC1_dom.
DR   InterPro; IPR034646; ADCK3_dom.
DR   InterPro; IPR034640; COQ8A.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   PANTHER; PTHR43851:SF1; PTHR43851:SF1; 1.
DR   Pfam; PF03109; ABC1; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Direct protein sequencing;
KW   Disease variant; Kinase; Membrane; Mitochondrion; Neurodegeneration;
KW   Nucleotide-binding; Primary mitochondrial disease; Reference proteome;
KW   Transferase; Transit peptide; Transmembrane; Transmembrane helix;
KW   Ubiquinone biosynthesis.
FT   TRANSIT         1..162
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:25498144"
FT   CHAIN           163..647
FT                   /note="Atypical kinase COQ8A, mitochondrial"
FT                   /id="PRO_0000000262"
FT   TRANSMEM        214..230
FT                   /note="Helical"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:25216398"
FT   DOMAIN          329..518
FT                   /note="Protein kinase"
FT   REGION          90..117
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          182..203
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           276..279
FT                   /note="KxGQ motif"
FT                   /evidence="ECO:0000269|PubMed:25498144"
FT   MOTIF           337..340
FT                   /note="AAAS motif"
FT                   /evidence="ECO:0000269|PubMed:25498144"
FT   ACT_SITE        488
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:27499294"
FT   BINDING         340
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:27499294,
FT                   ECO:0000305|PubMed:25498144, ECO:0000312|PDB:5I35"
FT   BINDING         358
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:27499294,
FT                   ECO:0000312|PDB:5I35"
FT   BINDING         445..448
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:27499294,
FT                   ECO:0000312|PDB:5I35"
FT   BINDING         493
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:27499294,
FT                   ECO:0000312|PDB:5I35"
FT   BINDING         507
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:27499294,
FT                   ECO:0000312|PDB:5I35"
FT   VAR_SEQ         1..484
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15498874"
FT                   /id="VSP_022351"
FT   VAR_SEQ         1..279
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_022352"
FT   VAR_SEQ         1..52
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_022353"
FT   VARIANT         85
FT                   /note="H -> Q (in dbSNP:rs2297411)"
FT                   /id="VAR_020319"
FT   VARIANT         213
FT                   /note="R -> W (in COQ10D4; dbSNP:rs119468005)"
FT                   /evidence="ECO:0000269|PubMed:18319072,
FT                   ECO:0000269|PubMed:22036850"
FT                   /id="VAR_044402"
FT   VARIANT         271
FT                   /note="R -> C (in COQ10D4; dbSNP:rs145034527)"
FT                   /evidence="ECO:0000269|PubMed:22036850"
FT                   /id="VAR_072622"
FT   VARIANT         272
FT                   /note="G -> D (in COQ10D4; dbSNP:rs119468006)"
FT                   /evidence="ECO:0000269|PubMed:18319072,
FT                   ECO:0000269|PubMed:22036850"
FT                   /id="VAR_044403"
FT   VARIANT         272
FT                   /note="G -> V (in COQ10D4; dbSNP:rs119468006)"
FT                   /evidence="ECO:0000269|PubMed:18319072,
FT                   ECO:0000269|PubMed:22036850"
FT                   /id="VAR_044404"
FT   VARIANT         299
FT                   /note="R -> W (in COQ10D4; decreased stability;
FT                   dbSNP:rs201908721)"
FT                   /evidence="ECO:0000269|PubMed:22036850,
FT                   ECO:0000269|PubMed:25498144, ECO:0000269|PubMed:27106809"
FT                   /id="VAR_072623"
FT   VARIANT         304
FT                   /note="A -> T (in COQ10D4; dbSNP:rs778798354)"
FT                   /evidence="ECO:0000269|PubMed:22036850"
FT                   /id="VAR_072624"
FT   VARIANT         304
FT                   /note="A -> V (in COQ10D4; dbSNP:rs748118737)"
FT                   /evidence="ECO:0000269|PubMed:22036850"
FT                   /id="VAR_072625"
FT   VARIANT         341
FT                   /note="I -> T (in dbSNP:rs55798516)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_045576"
FT   VARIANT         429
FT                   /note="Y -> C (in COQ10D4; decreased stability;
FT                   dbSNP:rs144147839)"
FT                   /evidence="ECO:0000269|PubMed:22036850,
FT                   ECO:0000269|PubMed:25498144"
FT                   /id="VAR_072626"
FT   VARIANT         514
FT                   /note="Y -> C (in COQ10D4; dbSNP:rs119468008)"
FT                   /evidence="ECO:0000269|PubMed:18319074"
FT                   /id="VAR_044405"
FT   VARIANT         549
FT                   /note="G -> S (in COQ10D4; decreased stability;
FT                   dbSNP:rs119468009)"
FT                   /evidence="ECO:0000269|PubMed:18319074,
FT                   ECO:0000269|PubMed:22036850, ECO:0000269|PubMed:25498144"
FT                   /id="VAR_044406"
FT   VARIANT         551
FT                   /note="E -> K (in COQ10D4; decreased stability;
FT                   dbSNP:rs119468004)"
FT                   /evidence="ECO:0000269|PubMed:18319072,
FT                   ECO:0000269|PubMed:22036850, ECO:0000269|PubMed:25498144"
FT                   /id="VAR_044407"
FT   VARIANT         578
FT                   /note="F -> V (in COQ10D4; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:27106809"
FT                   /id="VAR_076860"
FT   VARIANT         584
FT                   /note="Missing (in COQ10D4; dbSNP:rs387906299)"
FT                   /evidence="ECO:0000269|PubMed:18319074"
FT                   /id="VAR_044408"
FT   VARIANT         602
FT                   /note="P -> R (in COQ10D4; dbSNP:rs61995958)"
FT                   /evidence="ECO:0000269|PubMed:24048965"
FT                   /id="VAR_072627"
FT   MUTAGEN         214
FT                   /note="L->A,I,L,F: Strongly impairs homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         214
FT                   /note="L->I,F,G,V: Slightly impaired homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         215
FT                   /note="A->I,L,G: Does not impair homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         216
FT                   /note="N->A,L,F,M: Does not impair homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         217
FT                   /note="F->A: Slightly impaired homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         218
FT                   /note="G->I,L,F: Slightly impaired homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         219
FT                   /note="G->A,F: Slightly impaired homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         219
FT                   /note="G->I: Strongly impairs homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         220
FT                   /note="L->G: Impaired homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         221
FT                   /note="A->L: Slightly impaired homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         222
FT                   /note="V->A: Slightly impaired homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         223
FT                   /note="G->A,I,L,F: Strongly impairs homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         224
FT                   /note="L->V: Impaired homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         225
FT                   /note="G->L: Slightly impaired homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         226
FT                   /note="F->A: Slightly impaired homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         227
FT                   /note="G->V,F,L,I: Strongly impairs homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         228
FT                   /note="A->I,L,F: Does not impair homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         229
FT                   /note="L->A: Slightly impaired homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         230
FT                   /note="A->I: Slightly impaired homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25216398"
FT   MUTAGEN         276
FT                   /note="K->R,H: Does not affect selectivity for binding ADP
FT                   or ATP. Impaired multi-subunit COQ enzyme complex."
FT                   /evidence="ECO:0000269|PubMed:25498144,
FT                   ECO:0000269|PubMed:27499294"
FT   MUTAGEN         279
FT                   /note="Q->R,H: Does not affect selectivity for binding ADP
FT                   or ATP."
FT                   /evidence="ECO:0000269|PubMed:25498144"
FT   MUTAGEN         339
FT                   /note="A->G: Enables autophosphorylation but inhibits
FT                   coenzyme Q biosynthesis in vivo."
FT                   /evidence="ECO:0000269|PubMed:25498144"
FT   MUTAGEN         358
FT                   /note="K->R: Abolishes binding ADP or ATP."
FT                   /evidence="ECO:0000269|PubMed:25498144"
FT   MUTAGEN         405
FT                   /note="E->A,Q: Slightly affects selectivity for binding ADP
FT                   or ATP."
FT                   /evidence="ECO:0000269|PubMed:25498144"
FT   MUTAGEN         411
FT                   /note="E->Q: Impaired binding ADP or ATP."
FT                   /evidence="ECO:0000269|PubMed:25498144"
FT   MUTAGEN         488
FT                   /note="D->N: Impaired binding ADP or ATP."
FT                   /evidence="ECO:0000269|PubMed:25498144"
FT   MUTAGEN         493
FT                   /note="N->A: Impaired binding ADP or ATP."
FT                   /evidence="ECO:0000269|PubMed:25498144"
FT   MUTAGEN         507
FT                   /note="D->N: Strongly impairs binding ADP or ATP. Impaired
FT                   multi-subunit COQ enzyme complex."
FT                   /evidence="ECO:0000269|PubMed:25498144,
FT                   ECO:0000269|PubMed:27499294"
FT   MUTAGEN         611
FT                   /note="R->A,Q: Does not affect selectivity for binding ADP
FT                   or ATP."
FT                   /evidence="ECO:0000269|PubMed:25498144"
FT   CONFLICT        283..284
FT                   /note="IQ -> VR (in Ref. 4; BAC11143)"
FT                   /evidence="ECO:0000305"
FT   HELIX           260..269
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           271..281
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   STRAND          284..289
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           291..302
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           303..306
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           309..320
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           325..327
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   STRAND          328..331
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   STRAND          336..339
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   STRAND          342..349
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   STRAND          354..360
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   TURN            362..364
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           365..367
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           368..382
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   STRAND          387..389
FT                   /evidence="ECO:0007829|PDB:5I35"
FT   HELIX           391..393
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           395..405
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           408..421
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   TURN            422..424
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   STRAND          426..429
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           435..437
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   STRAND          442..446
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   STRAND          450..452
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           453..455
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           461..480
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   STRAND          484..488
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           491..493
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   STRAND          494..497
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   TURN            498..501
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   STRAND          502..505
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           508..510
FT                   /evidence="ECO:0007829|PDB:5I35"
FT   STRAND          511..513
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           516..530
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           534..543
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           553..571
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           581..588
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           589..594
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   STRAND          596..600
FT                   /evidence="ECO:0007829|PDB:5I35"
FT   HELIX           604..622
FT                   /evidence="ECO:0007829|PDB:4PED"
FT   HELIX           630..643
FT                   /evidence="ECO:0007829|PDB:4PED"
SQ   SEQUENCE   647 AA;  71950 MW;  DEF8F022027BF6CC CRC64;
     MAAILGDTIM VAKGLVKLTQ AAVETHLQHL GIGGELIMAA RALQSTAVEQ IGMFLGKVQG
     QDKHEEYFAE NFGGPEGEFH FSVPHAAGAS TDFSSASAPD QSAPPSLGHA HSEGPAPAYV
     ASGPFREAGF PGQASSPLGR ANGRLFANPR DSFSAMGFQR RFFHQDQSPV GGLTAEDIEK
     ARQAKARPEN KQHKQTLSEH ARERKVPVTR IGRLANFGGL AVGLGFGALA EVAKKSLRSE
     DPSGKKAVLG SSPFLSEANA ERIVRTLCKV RGAALKLGQM LSIQDDAFIN PHLAKIFERV
     RQSADFMPLK QMMKTLNNDL GPNWRDKLEY FEERPFAAAS IGQVHLARMK GGREVAMKIQ
     YPGVAQSINS DVNNLMAVLN MSNMLPEGLF PEHLIDVLRR ELALECDYQR EAACARKFRD
     LLKGHPFFYV PEIVDELCSP HVLTTELVSG FPLDQAEGLS QEIRNEICYN ILVLCLRELF
     EFHFMQTDPN WSNFFYDPQQ HKVALLDFGA TREYDRSFTD LYIQIIRAAA DRDRETVRAK
     SIEMKFLTGY EVKVMEDAHL DAILILGEAF ASDEPFDFGT QSTTEKIHNL IPVMLRHRLV
     PPPEETYSLH RKMGGSFLIC SKLKARFPCK AMFEEAYSNY CKRQAQQ
//
